Financials

News Ideas Discussions Technicals Forecast Seasonals

0QNA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) operating, investing, and financing activities

0QNA free cash flow for H2 24 is 55.2 M CHF. For 2024, 0QNA free cash flow was 72.65 M CHF and operating cash flow was 74.36 M CHF.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CHF

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—